These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 7473077)
1. Pharmacodynamic model for joint exogenous and endogenous corticosteroid suppression of lymphocyte trafficking. Milad MA; Ludwig EA; Anné S; Middleton E; Jusko WJ J Pharmacokinet Biopharm; 1994 Dec; 22(6):469-80. PubMed ID: 7473077 [TBL] [Abstract][Full Text] [Related]
2. Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone. Chow FS; Sharma A; Jusko WJ J Pharmacokinet Biopharm; 1999 Dec; 27(6):559-75. PubMed ID: 11153446 [TBL] [Abstract][Full Text] [Related]
3. Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids. Meibohm B; Derendorf H; Möllmann H; Fröhlich P; Tromm A; Wagner M; Homrighausen S; Krieg M; Hochhaus G Int J Clin Pharmacol Ther; 1999 Aug; 37(8):367-76. PubMed ID: 10475139 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm. Fisher LE; Ludwig EA; Wald JA; Sloan RR; Middleton E; Jusko WJ Clin Pharmacol Ther; 1992 Jun; 51(6):677-88. PubMed ID: 1535301 [TBL] [Abstract][Full Text] [Related]
5. Pharmacoimmunodynamics of methylprednisolone: trafficking of helper T lymphocytes. Fisher LE; Ludwig EA; Jusko WJ J Pharmacokinet Biopharm; 1992 Aug; 20(4):319-31. PubMed ID: 1479558 [TBL] [Abstract][Full Text] [Related]
6. Circadian rhythms in circulating T lymphocyte subtypes and plasma testosterone, total and free cortisol in five healthy men. Lévi FA; Canon C; Touitou Y; Sulon J; Mechkouri M; Ponsart ED; Touboul JP; Vannetzel JM; Mowzowicz I; Reinberg A Clin Exp Immunol; 1988 Feb; 71(2):329-35. PubMed ID: 2964961 [TBL] [Abstract][Full Text] [Related]
7. CD4+ and CD8+ lymphocyte and cortisol response patterns in elderly and young males after methylprednisolone exposure. Tornatore KM; Venuto RC; Logue G; Davis PJ J Med; 1998; 29(3-4):159-83. PubMed ID: 9865456 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the administration time effect on the cumulative cortisol suppression and cumulative lymphocytes suppression for once-daily inhaled corticosteroids: a population modeling/simulation approach. Wu K; Goyal N; Stark JG; Hochhaus G J Clin Pharmacol; 2008 Sep; 48(9):1069-80. PubMed ID: 18728243 [TBL] [Abstract][Full Text] [Related]
9. A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids. Meibohm B; Hochhaus G; Möllmann H; Barth J; Wagner M; Krieg M; Stöckmann R; Derendorf H J Pharmacokinet Biopharm; 1999 Apr; 27(2):127-47. PubMed ID: 10567952 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity. Dunn TE; Ludwig EA; Slaughter RL; Camara DS; Jusko WJ Clin Pharmacol Ther; 1991 May; 49(5):536-49. PubMed ID: 1827621 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of glucose regulation by methylprednisolone. II. normal rats. Jin JY; Jusko WJ Biopharm Drug Dispos; 2009 Jan; 30(1):35-48. PubMed ID: 19156669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]